VITZROCELL Co.Ltd (082920) - Total Liabilities
Based on the latest financial reports, VITZROCELL Co.Ltd (082920) has total liabilities worth ₩49.86 Billion KRW (≈ $33.79 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore 082920 shareholders equity momentum to track the company's year-over-year net asset growth rate.
VITZROCELL Co.Ltd - Total Liabilities Trend (2012–2025)
This chart illustrates how VITZROCELL Co.Ltd's total liabilities have evolved over time, based on quarterly financial data. See VITZROCELL Co.Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
VITZROCELL Co.Ltd Competitors by Total Liabilities
The table below lists competitors of VITZROCELL Co.Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Beijing Succeeder Technology Inc
SHG:688338
|
China | CN¥69.11 Million |
|
Hebei Gongda Keya Energy Technology Co. Ltd. A
SHE:301197
|
China | CN¥339.40 Million |
|
MCI Management SA
WAR:MCI
|
Poland | zł282.41 Million |
|
Tivan Ltd
AU:TVN
|
Australia | AU$13.44 Million |
|
Impulse Qingdao Health Tech Co Ltd
SHE:002899
|
China | CN¥1.09 Billion |
|
Shenzhen Genvict Technologies Co Ltd
SHE:002869
|
China | CN¥421.92 Million |
|
Oncology Institute Inc
NASDAQ:TOI
|
USA | $184.51 Million |
Liability Composition Analysis (2012–2025)
This chart breaks down VITZROCELL Co.Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see VITZROCELL Co.Ltd market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 5.97 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.15 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.13 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how VITZROCELL Co.Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for VITZROCELL Co.Ltd (2012–2025)
The table below shows the annual total liabilities of VITZROCELL Co.Ltd from 2012 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | ₩40.35 Billion ≈ $27.34 Million |
+15.81% |
| 2024-12-31 | ₩34.84 Billion ≈ $23.61 Million |
+41.94% |
| 2023-12-31 | ₩24.54 Billion ≈ $16.63 Million |
-52.32% |
| 2022-12-31 | ₩51.48 Billion ≈ $34.89 Million |
+30.31% |
| 2021-12-31 | ₩39.50 Billion ≈ $26.77 Million |
+21.78% |
| 2020-12-31 | ₩32.44 Billion ≈ $21.98 Million |
+44.09% |
| 2019-12-31 | ₩22.51 Billion ≈ $15.26 Million |
-9.59% |
| 2018-12-31 | ₩24.90 Billion ≈ $16.88 Million |
+0.57% |
| 2017-12-31 | ₩24.76 Billion ≈ $16.78 Million |
+77.11% |
| 2016-12-31 | ₩13.98 Billion ≈ $9.47 Million |
-40.40% |
| 2015-12-31 | ₩23.46 Billion ≈ $15.90 Million |
+4.04% |
| 2014-12-31 | ₩22.55 Billion ≈ $15.28 Million |
+100.40% |
| 2014-06-30 | ₩11.25 Billion ≈ $7.62 Million |
-9.60% |
| 2013-12-31 | ₩12.45 Billion ≈ $8.43 Million |
+51.03% |
| 2012-12-31 | ₩8.24 Billion ≈ $5.58 Million |
-- |
About VITZROCELL Co.Ltd
VITZROCELL Co.,Ltd. engages in the production and sale of lithium batteries in South Korea and the United States. The company was formerly known as Teckraf Co., Ltd. and changed its name to VITZROCELL Co., Ltd. in June 2002. VITZROCELL Co.,Ltd. was founded in 1987 and is headquartered in Dangjin, South Korea.